These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 4723113)
1. Vascular lesions in hemophilia B. Steinberg MH; Breiling BJ N Engl J Med; 1973 Sep; 289(11):592. PubMed ID: 4723113 [No Abstract] [Full Text] [Related]
2. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature. Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916 [TBL] [Abstract][Full Text] [Related]
3. Current management of hemophilia B. Roberts HR; Eberst ME Hematol Oncol Clin North Am; 1993 Dec; 7(6):1269-80. PubMed ID: 8294316 [TBL] [Abstract][Full Text] [Related]
4. Steps toward improved safety of treatment in hemophilia B. Goldsmith JC J Lab Clin Med; 1993 Mar; 121(3):370-1. PubMed ID: 8445281 [No Abstract] [Full Text] [Related]
5. Summary report and recommendations of the task force members and consultants. Ménachd ; Roberts HR Thromb Diath Haemorrh; 1975 Jun; 33(3):645-7. PubMed ID: 1154320 [No Abstract] [Full Text] [Related]
6. [Clinical use of factor IX concentrates]. Nyman D Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to factor IX. Warrier I Haematologica; 2000 Oct; 85(10 Suppl):31-3; discussion 33-4. PubMed ID: 11187867 [No Abstract] [Full Text] [Related]
9. Thrombogenicity associated with factor IX complex concentrates. Lusher JM Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767 [No Abstract] [Full Text] [Related]
10. Serial changes in the coagulation system following clotting factor concentrate infusion. Preston FE; Winfield DA; Malia RG; Blackburn EK Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408 [TBL] [Abstract][Full Text] [Related]
11. Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case series. Kleiboer B; Nielsen B; Ma AD; Abajas Y; Monroe DM; Key NS Haemophilia; 2020 Jan; 26(1):e23-e25. PubMed ID: 31778004 [No Abstract] [Full Text] [Related]
12. [Factor IX inhibitor in hemophilia B presented with anaphylactoid symptoms: report of 3 cases]. Taketani T; Hanada R; Kawaguchi H; Ida K; Yamamoto K Rinsho Ketsueki; 1999 Oct; 40(10):1124-6. PubMed ID: 10565232 [TBL] [Abstract][Full Text] [Related]
13. Thrombosis and factor-IX concentrates. Machin SJ; Miller BE Lancet; 1978 Jun; 1(8078):1367. PubMed ID: 78138 [No Abstract] [Full Text] [Related]
14. Transfusion support for haemophiliacs. Allain JP Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835 [No Abstract] [Full Text] [Related]
15. Off-pump myocardial revascularization in a diabetic patient with severe hemophilia B and impaired left ventricular function: hematological and operative strategies. Grandmougin D; Delolme MC; Reynaud J; Barral X J Card Surg; 2005; 20(4):366-9. PubMed ID: 15985141 [TBL] [Abstract][Full Text] [Related]
16. Recombinant factor IX for the treatment of hemophilia B. Introduction. Thompson A Semin Hematol; 1998 Apr; 35(2 Suppl 2):1-3. PubMed ID: 9565159 [No Abstract] [Full Text] [Related]
17. Disseminated intravascular coagulation after factor IX complex resolved using purified factor IX concentrate. Hadley T; Djulbegovic B Ann Intern Med; 1991 Oct; 115(8):621-2. PubMed ID: 1892334 [No Abstract] [Full Text] [Related]
19. Management of haemostasis during haemodialysis in a patient with haemophilia B. Fujii T; Takata N; Saito S; Naito T; Kimura A Haemophilia; 2008 Sep; 14(5):1135-7. PubMed ID: 18665852 [No Abstract] [Full Text] [Related]
20. [The successful use of FEIBA for treatment of intracranial hemorrhage in a patient of hemophilia B with inhibitor]. Taki M; Inagaki M; Tomita Y; Miura T; Saito N; Meguro T; Yamada K Rinsho Ketsueki; 1985 Aug; 26(8):1300-5. PubMed ID: 3877831 [No Abstract] [Full Text] [Related] [Next] [New Search]